Pons Jaume's Form 4 filing
Alx Oncology Holdings Inc (ALXO) · filed Apr 5, 2024
- Accession no.
- 0001415889-24-010443
- Filed
- Apr 5, 2024
- Trade date
- Apr 4, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $223.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pons JaumeCIK 0001816977 | Director, Officer (PRESIDENT & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Common Stock | SSaleDisposed | −20,000 | $11.15 | −$223,000 | 628,359 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.